Search results for "growth"

showing 10 items of 5134 documents

Health indicators as indicators of the progress of civilization

2018

medicine.medical_specialtyEconomic growthCivilizationPolitical sciencemedia_common.quotation_subjectPublic healthmedicinePopulation healthHealth indicatormedia_commonZdrowie Publiczne i Zarządzanie
researchProduct

Rare diseases and orphan drugs: Latvian story

2014

Background Ten years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in the public health system, though there are significant differences in the national healthcare services for rare diseases among the EU States. This study aims to determine situation in the field of rare diseases in Latvia and compare it with other European countries. Methods We used the national plan for rare diseases, EUCERD reports, Orphanet data, Latvian and European regulations, publicly availa…

medicine.medical_specialtyEconomic growthNational Health ProgramsOrphan Drug ProductionLegislationReviewPharmacologyOrphan drugRare DiseasesPolitical scienceOrphan Drug ProductionHealth caremedicineMember stateHumansOrphan drugsGenetics(clinical)Pharmacology (medical)Genetics (clinical)Medicine(all)business.industryPublic healthLatvianAvailabilityLegislatureGeneral MedicineLegislation DrugAccessibilityLatvialanguage.human_languageEuropelanguagebusinessOrphanet Journal of Rare Diseases
researchProduct

The policy of public health genomics in Italy.

2013

Abstract Italy has a monitoring system for genetic testing, consisting in a periodic census of clinical and laboratory activities performed in the country. The experience is limited, however, concerning the translation of genomic testing for complex diseases into clinical practice. For the first time the Italian Ministry of Health has introduced a policy strategic plan on genomics and predictive medicine within the 2010–2012 National Prevention Plan. This achievement was supported by the Italian Network for Public Health Genomics (GENISAP) and will likely contribute to the integration of public health genomics into health care in the country. Our experience might be of interest not only in …

medicine.medical_specialtyEconomic growthpublic health genomicsSettore MED/03 - GENETICA MEDICASettore MED/42 - Igiene Generale E ApplicataPredictive medicinepredictive medicineEnvironmental healthHealth caremedicineNational PolicyHumansGenetic Testingpolicy genomicsHealth policyGenetic testingStrategic planningnational policyPublic health genomicsmedicine.diagnostic_testbusiness.industryPublic healthHealth PolicyGenetic Diseases InbornGenomicspublic health genomics public health policyHealth PlanningInbornItalyGenetic DiseasesPublic HealthbusinessDelivery of Health Carepolicypublic health genomics; predictive medicine; national policyHealth policy (Amsterdam, Netherlands)
researchProduct

Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction

2021

Abstract Introduction and objectives Angiogenesis helps to reestablish microcirculation after myocardial infarction (MI). In this study, we aimed to further understand the role of the antiangiogenic isoform vascular endothelial growth factor (VEGF)-A165b after MI and to explore its potential as a coadjuvant therapy to coronary reperfusion. Methods Two mice MI models were formed: a) permanent coronary ligation (nonreperfused MI); b) transient 45-minute coronary occlusion followed by reperfusion (reperfused MI); in both models, animals underwent echocardiography before euthanasia at day 21 after MI induction. We determined serum and myocardial VEGF-A165b levels. In both experimental MI models…

medicine.medical_specialtyEjection fractionbusiness.industryAngiogenesisGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseMicrocirculationBlockadeVascular endothelial growth factor03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistryCoronary occlusionHeart failureInternal medicinemedicineCardiologyMyocardial infarctionbusinessRevista Española de Cardiología (English Edition)
researchProduct

Longitudinal Study on Growth and Body Mass Index before and after Diagnosis of Childhood Craniopharyngioma

2004

Abstract We analyzed whether childhood craniopharyngioma predisposes to obesity and growth impairment. Height/length, body mass index (BMI), and hypothalamic involvement were evaluated in 90 patients at standardized ages and time points before, after, and at the time of diagnosis. Relevant decreases in height sd score (SDS) started at 10–12 months of age and persisted until diagnosis of childhood craniopharyngioma. Relevant increases in BMI SDS were detectable between 4 and 5 yr of age. Postoperative BMI SDS (yr 1–6) had a weak positive correlation with BMI SDS at the time of diagnosis. In linear regression analysis, hypothalamic tumor involvement (P < 0.001), ponderal index at birth…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismClinical BiochemistryHypothalamusPituitary neoplasmBiochemistryBody Mass IndexCraniopharyngiomaChild DevelopmentEndocrinologyRisk FactorsInternal medicinemedicineHumansNeoplasm InvasivenessPituitary NeoplasmsLongitudinal StudiesObesityRisk factorGrowth DisordersRetrospective Studiesbusiness.industryBody WeightBiochemistry (medical)Childhood CraniopharyngiomaInfantmedicine.diseaseObesityBody HeightCraniopharyngiomaEndocrinologyEl NiñoMultivariate AnalysisHypothalamic NeoplasmDisease SusceptibilitybusinessBody mass indexThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk1

2012

medicine.medical_specialtyEndocrinologyEndocrinologybusiness.industryEndocrinology Diabetes and MetabolismInternal medicinemedicinemedicine.diseasebusinessObesityGrowth hormone secretionLipoproteinClinical Endocrinology
researchProduct

Hepatocyte growth factor induces a protective effect in cerulein-induced acute pancreatitis in mice

2016

medicine.medical_specialtyEndocrinologyHepatologybusiness.industryEndocrinology Diabetes and MetabolismInternal medicineGastroenterologymedicineAcute pancreatitisHepatocyte growth factormedicine.diseasebusinessmedicine.drugPancreatology
researchProduct

PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars: The Case of Epoetine, Granulocyte-Colony Stimulating Factor, a…

2012

medicine.medical_specialtyEndocrinologyInternal medicineHealth PolicymedicinePublic Health Environmental and Occupational HealthBiosimilarBiologyGrowth hormoneGranulocyte colony-stimulating factorMarket penetrationValue in Health
researchProduct

Author response: Mutations in SKI in Shprintzen–Goldberg syndrome lead to attenuated TGF-β responses through SKI stabilization

2020

medicine.medical_specialtyEndocrinologybusiness.industryInternal medicineMedicineShprintzen–Goldberg syndromebusinessmedicine.diseaseTransforming growth factor
researchProduct

NAM Therapy-Evidence-Based Results

2020

Many orthodontists working on patients with cleft lip and palate (CLP) have shown great enthusiasm for presurgical infant orthopedics (PSIO) to improve surgical outcomes with minimal intervention. Even though every clinician aims to use the best treatment modality for their patients, PSIO effects can be confounded by surgical type and timing of the primary repair, as is discussed in many studies. In such cases, one should be cautious when evaluating the particular outcomes for patients with CLP since it is difficult to differentiate the sole effect of an individual surgical or orthodontic intervention. As with any treatment methodology, nasoalveolar molding (NAM) has both benefits and limi…

medicine.medical_specialtyEvidence-based practiceinfant orthopedicmedicine.medical_treatmentCleft Lipmidfacial growthNoseBurden of care03 medical and health sciencesPrimary repair0302 clinical medicineIntervention (counseling)medicineDeformityMaxillaHumansOrthopedic Procedures030223 otorhinolaryngologyIntensive care medicineMaxillary growthReduction (orthopedic surgery)business.industryInfant orthopedicsInfant030206 dentistryPlastic Surgery ProceduresCleft PalateOtorhinolaryngologyfacial growthOral Surgerymedicine.symptombusinessnonsyndromic clefting
researchProduct